RINGSIDE trial
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
Immunome; Q3 2025; financial results; business update; pipeline update; cancer therapies; RINGSIDE trial; varegacestat; IM-1021; B-cell lymphoma; clinical trials; ADC; net loss; cash position